By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported 5 percent revenue growth on the strength of its fine chemicals business. Excluding the effect of foreign currency exchange rates, its revenues were up 7 percent.

The St. Louis-based research products and chemicals firm brought in total revenues of $563 million for the three-month period ended Sept. 30, compared with $534 million for Q3 2009. Analysts, on average, had expected sales of $542.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.